Yongjun Chen: Clinical Trials

1 trial sponsored by Yongjun Chen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Yongjun Chen: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer
Adebrelimab combined with the GC regimen and Apatinib - Biliary Tract Cancer, Biliary Tract Cancer (CCA)
Phase 2RecruitingYongjun Chen372025-08-142025-08-22

Conditions studied

Biliary Tract Neoplasms (1)

Interventions

apatinib (1)

Countries

China (1)